New York, NY · Founded 2019 · Privately Held (backing)
Developer of an ECG (Electrocardiogram)-based diagnostics software platform intended to enhance interpretation of electrocardiogram data for improved detection of cardiovascular and metabolic… AccurKardia is based in New York, NY and was founded in 2019. It has raised $9 million across 1 recorded round; the latest was a $4.1 million seed round in Aug 2022.
Last price · $/share
—
Implied valuation
—
Total raised
$9.0M
Last round
Seed Round
Aug 2022
No prints on record
No secondary trades in AccurKardia shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AccurKardia with a free account
·Watch AccurKardia: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of AccurKardia stock.
